Dyslipidemia and CVD part 1 Flashcards

1
Q

hypolipoproteinemias 3 examples

A
  1. abetalipoproteinemia

2. familial hypobetalipoproteinemia 3. tangier disease ( alpha-lipoprotein deficiency )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

abetalipoproteinemia

A

defect in app B synth

- no chiylo, VLDL, LDL and TG accumulate in the liver and intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

familial hypobetalipoproteinemia

A

LDL concentration is 10-50% of normal but chill formation occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

tangier disease

A

absence of HDL, CE accumulate in tissues, chill, VLDL, LDL all normal,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

most common hyperlipoproteinemia phenotypes

A

IIb (LDL and VLDL- mutation of LDL receptor and app B) and IV (VLDL)- but no marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

majority of genotype for apo-E

A

60% have E-3/E-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what’s the bad one of apo-E

A

E-2/E-2 bc it does not bind to the LDL receptor so increased VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

primary dyslipidemia classification?

A

single or poly-genetic abnormality affecting lipoprotein function resulting in hyper to hip lipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

type 1 - hyperchylomicronemia

A

high TG, low HDL, skin xANTHOMAS, PANCREATITIS,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

type IIa- hypercholesterolemia

A

high LDL and Tg normal or high,

symptoms: xanthekasma, vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

type IIb- combined hyperlipoproteinemia

A

high LDL and VLDL and high apo-B

serum: high chol, high TG and low HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

type III- dysbetalipoproteinemia

A

high b-VLDL IDL

and high LDL and VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

type IV- hypertriglyceridem a

A

high VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

type V- mixed hyperlipidemia

A

high VLDL, and CM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Total CH

A

less than 5.2mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HDL levels

A

want more than 1.0 men

more than 1.3 in women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LDL levels

A

want less than 2.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TG levels

A

want less than 1.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

apoproteins

A

primary determinant of the metabolic fate of lipoproteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

VLDL major apoproteins

A

B-100 and E and C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LDL major apoprotein

A

B-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HDL major apoprotein

A

A1, AII, C, E

23
Q

CM major apoproteins

A

B-48, E, A1, AIV, C11, C111

24
Q

Apo e-2 does not bind to

A

LDL receptor ( so higher VLDL ruminants)

25
Q

defect in app B synth ( no CM, VLDL, LDL formed and TG accumulate in liver and intestine

A

abetalipoproteinemia

26
Q

LDL is 10-15% of normal but CM still occurs

A

familial hypobetalipoprotinemia

27
Q

Tangier disease

A

absence of HDL
- no apo A-II
- can’t take away CE from tissues ( so accumulate)
CM, VLDL, LDL are normal

28
Q

which hyperlipidemias have the greatest CVD risk? why?

A

IIb ( combined hyperlipoprotinemia) and III dysbetalipoproteinemia)

  • bc high in both LDL and VLDL
29
Q

hyperchylomicronemia

A

no CVD risk

this is when there is low LPL so CM accumulatie, leading to high TG and low HDL

30
Q

Hypercholesterolemia

A

polygenic- affecting LDL receptors and means that there are higher levels of LDL-C circulating but normal TG ( or high) ( + CVD risk)

31
Q

combined hyperlipoproteinemia

A

+++ CVD risk
- mutation in LDL receptor or APO B such that there is high LDL and VLDL
( so high CE and high TG with low HDL)

32
Q

dys-beta-lipo-protein-emia

33
Q

high TG and VLDL ?

A

IV- hypertriglyceridemia

34
Q

in type V- why is there a white band at the top?

A
CM floating ( the least dense) 
- this is mixed hyperlipidemia ( with high VLDL - like in hypertriglyceridemia) but this one is different bc also has high CM
35
Q

when will blood look more white?

A

when there is accumulation of TG from CM or VLDL

36
Q

why does IIA ( hypercholesterolemia look normal?

A

high CH, from LDL but TG are normal

37
Q

what are some medications that can cause secondary dyslipidemia?

A

thiazide diuretics, B- blockers, corticosteroids, estrogens,

38
Q

HSL role in obesity and lipoprotein metabolism

A

activity is increased bc high adipose tissue and if insulin resistance there is a lot of insulin being produced levels

  • end result is increased substrate flux to the liver
39
Q

describe the effect of alcohol on VLDL levels

A

ethanol blocks the pathway of acyl-CoA to oxidation ( for energy) so more acetyl-CoA will get converted to TG and get packaged in VLDL
- more VLDL, more lipolysis, more TG uptake into tissues ( fat deposit)

40
Q

effect of obesity on lipoprotein metabolism

A

over production of VLDL, increased lipolysis ( normal levels of VLDL but higher fat deposit)

41
Q

how does hyper-triglyceremia happen with obesity?

A
VLDL defect. 
lipolytic effect (high TG if high VLDL)
42
Q

how would hyper-cholesterolemia come from obesity?

A

LDL

  • if there was a defect in the LDL receptor
  • a diet very high in sat fats
43
Q

posible mechanism for reduced HDL in obesity?

A

CE get transferred to VLDL and HDL takes up a TG, when this happens excessively, increased catabolism of HDL bc lots more adipose tissue

44
Q

2 factors associated with low HDL in obesity?

A

severity (BMI)
- inverse relationship between HDL ( this is a stronger affect than the effect of raised LDL and obesity)

and distribution ( abdominal)

45
Q

what casues the decrease in HDL in obesity?

A

enhanced uptake of HDL2 by adipocytes and and increase in catabolism of apolipoprotein A-1

46
Q

who should be screened?

A

all mena nd women over the age of 40

- abdominal aortic aneurysm, obesity, Diabetes, hypertension, family history of premature CVD

47
Q

FRS

A

is a test that estimates your 10-year cardiovascular disease risk

we use this information to stratify the risk - so if FRS is above20% high risk, if between 10-19% intermediate risk

48
Q

when does FRS double?

A

if person is aged 30-55 without diabetes and has a relative with premature CVD

49
Q

which are the 5 statin indicated conditions

A
  1. atherosclerosis, 2.diabetes, 3.chronic kidney disease, 4.abdominal aortic aneurysm
  2. LDL more than 5mmol/L
50
Q

CVD intermediate risk ?

A

FRS of 10-19%
LDL > 3.5 ( should be under 2.6)
non-HDL > 4.3
or men or women with one of more psi factor that are one the age of 50 ( men and 60 women)

51
Q

what 2 methods as alternatives for LDL

A

non-HDL-C and apo-B as alternative targets

52
Q

primary target for high risk (>20% FRS)

53
Q

primary target if intermediate risk and LDL is greater that 3.5?

54
Q

primary target if low risk but LDL is greater than 5.0 so we initiate treatment ( <10% FRS)

A

> 50% decrease in LDL-C